AMI KHUU: Open Payments
NPI 1518615202 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 51 payments from 15 companies in 2025. Trend: 2023 $953 · 2024 $1,550 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $193 |
| Corium, LLC | 6 | $180 |
| Otsuka America Pharmaceutical, Inc. | 6 | $132 |
| Janssen Pharmaceuticals, Inc | 7 | $125 |
| Lundbeck LLC | 4 | $92 |
| Neurocrine BioSciences, Inc. | 3 | $90 |
| Teva Pharmaceuticals USA, Inc. | 3 | $80 |
| ABBVIE INC. | 4 | $78 |
| Exact Sciences Corporation | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
Products named: REXULTI, CAPLYTA, Azstarys, INGREZZA, AUSTEDO XR, VRAYLAR, INVEGA SUSTENNA, SPRAVATO.
Industry payments across TX — which companies pay providers there.
